Cian Healthcare share price
Balanced risk
You have to be logged in to add this to Watchlist.- ₹3.10(1.97%)April 28, 2025 14:49:59 PM IST
- NSE
- BSE
- Vol : 24.00K (NSE + BSE)Last 20 day avg : 41.70 K
Cian Healthcare is trading 1.97% upper at Rs 3.10 as compared to its last closing price. Cian Healthcare has been trading in the price range of 3.10 & 3.07. Cian Healthcare has given -21.45% in this year & -4.40% in the last 5 days. The company posted a net profit of -18.25 Crores in its last quarter.Listed peers of Cian Healthcare include Hindustan Bio Sciences (1.28%), Evoq Remedies (1.88%), Cian Healthcare (1.97%).The Mutual Fund holding in Cian Healthcare was at -% in . The MF holding has - from the last quarter. The FII holding in Cian Healthcare was at -% in . The FII holding has - from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Key Metrics
Updated on Apr 28, 2025, 09:49 PM UTC
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/BLower than historical values0.13The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values0.00Price-to-earnings ratio based on trailing 12-month earnings
- BetaLow volatility-0.24Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.96The debt-to-equity ratio, indicating a company's financial leverage.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Cian Healthcare News
Cian Healthcare Financials
Financials
View allFinancials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
- Income
- Balance Sheet
- Cash Flow
Loading...
Units in the chart are in crores
Insights
- Financial
- Valuation
Company is not profitable- The company's revenue fell during September quarter by 50.11% from Rs 37.88 crore to Rs 18.90 crore, year-on-year
- Company has registered a loss of 18.25 cr vs a profit of 0.48 cr in the same quarter last year.
- The debt to equity of the company is higher than the industry median
- Earnings are insufficient to cover the interest expenses on outstanding debt
Cian Healthcare Technical Analysis
Pivot Level - classic
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
- R1
- 3.64
- R2
- 3.82
- R3
- 4.15
Pivot3.31
- S1
- 3.13
- S2
- 2.80
- S3
- 2.62
Short Term
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Considers price movement over the last 6 months
Not Available
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Trends unavailable at the moment.
Cian Healthcare Peers
Return Comparison
Peers Comparison
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Hindustan Bio Sciences | Bearish | 7.89 | 1.28 | 8.09 | 138.66 | 9.93 | - | 317.88 |
| Evoq Remedies | Neutral | 3.25 | 1.88 | 8.09 | 79.75 | 0.18 | - | - |
| Cian Healthcare | Bearish | 3.10 | 1.97 | 7.75 | 30.72 | 0.13 | - | 47.62 |
| Adline Chem Lab | Neutral | 12.57 | - | 7.35 | - | - | - | |
| Kobo Biotech | Neutral | 3.00 | 4.17 | 7.15 | - | - | - |
Cian Healthcare Shareholding
View AllShareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
Shareholding pattern for Cian Healthcare is currently unavailable
Please check back later.
Shareholding Insights
Shareholding insights for Cian Healthcare are currently unavailable
Please check back later.
Cian Healthcare Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2024-07-12 | Preferential issue of shares |
| 2024-07-09 | Preferential issue of shares |
| 2024-06-14 | Others |
| 2024-06-05 | Others |
| 2024-05-30 | Audited Results |
About the company Cian Healthcare
- IndustryBiotechnology & Drugs
- ISININE05BN01019
- BSE Code542678
- NSE Code
Cian Healthcare Limited is an India-based company, which is engaged in the manufacturing and marketing of pharmaceutical products. The Company is engaged in manufacturing of multiple lines-tablets, capsules, soft gels, liquid orals, ointments/ creams and sachets, cosmetics. The Company operates in five sectors, such as Export, Government Supplies, Merchant Export, Own Brand Franchise Business and Third Party/ Contract manufacturing. Its portfolio comprises gynecology, haematinic, cardio- diabetic, orthopedic, pediatric, derma-cosmetic, and antibiotic, CNS, vitamin and nutrient products. The Company also exports its product to various countries, such as Afghanistan, Benin, Bhutan, Bolivia, Cambodia, Sri Lanka, Myanmar and also enhances its production capacity by installing additional machinery for manufacturing a variety of products. It is also engaged in the business of manufacturing cosmetic products. The Company's subsidiary includes Dr. Smith Biotech Private Limited.
Cian Healthcare Share Price FAQs
Cian Healthcare is trading at 3.10 as on Mon Apr 28 2025 09:19:59. This is 1.97% upper as compared to its previous closing price of 3.04.
The market capitalization of Cian Healthcare is 7.75 Cr as on Mon Apr 28 2025 09:19:59.
The 52 wk high for Cian Healthcare is 26.50 whereas the 52 wk low is 2.97
Cian Healthcare can be analyzed on the following key metrics -
- TTM P/E:
- Sector P/E: 26.62
- Dividend Yield: 0.00%
- D/E ratio: 1.36
Cian Healthcare reported a net profit of 0.25 Cr in 2024.
Quick Links